Klaria Pharma Holding AB (KLAR) — Cash Flow-to-Debt Ratio
Klaria Pharma Holding AB (KLAR) has a Cash Flow-to-Debt Ratio of 0.00x as of March 2026, meaning its operating cash flow of Skr-82.00K could theoretically repay 0% of its total liabilities (Skr50.62 Million) in one year. See Klaria Pharma Holding AB free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Klaria Pharma Holding AB Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Klaria Pharma Holding AB across 11 annual periods. For the full cash flow conversion analysis, see Klaria Pharma Holding AB operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Klaria Pharma Holding AB (2015–2025)
Year-by-year debt coverage analysis for Klaria Pharma Holding AB. Check KLAR operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.78x | Skr-35.04 Million | Skr44.65 Million | ▼ -254.8% |
| 2024 | -0.22x | Skr-11.94 Million | Skr53.96 Million | ▲ +22.3% |
| 2023 | -0.28x | Skr-9.06 Million | Skr31.81 Million | ▲ +74.7% |
| 2022 | -1.13x | Skr-49.73 Million | Skr44.19 Million | ▼ -121.9% |
| 2021 | -0.51x | Skr-24.80 Million | Skr48.89 Million | ▲ +67.2% |
| 2020 | -1.55x | Skr-35.30 Million | Skr22.81 Million | ▼ -105.1% |
| 2019 | -0.75x | Skr-14.80 Million | Skr19.62 Million | ▲ +4.5% |
| 2018 | -0.79x | Skr-9.13 Million | Skr11.55 Million | ▲ +84.6% |
| 2017 | -5.13x | Skr-12.06 Million | Skr2.35 Million | ▲ +28.9% |
| 2016 | -7.22x | Skr-14.39 Million | Skr1.99 Million | ▼ -273.7% |
| 2015 | -1.93x | Skr-4.43 Million | Skr2.29 Million | — |